Non-Tyrosine Kinase Inhibitors Market - Global Outlook and Forecast 2021-2027

Code: RW00014561055
Market Monitor Global
Oct-2021
Life Sciences
106 Pages

This report contains market size and forecasts of Non-Tyrosine Kinase Inhibitors in global, including the following market information:
Global Non-Tyrosine Kinase Inhibitors Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Non-Tyrosine Kinase Inhibitors Market Sales, 2016-2021, 2022-2027, (K Pcs)
Global top five Non-Tyrosine Kinase Inhibitors companies in 2020 (%)
The global Non-Tyrosine Kinase Inhibitors market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Non-Tyrosine Kinase Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Non-Tyrosine Kinase Inhibitors Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Non-Tyrosine Kinase Inhibitors Market Segment Percentages, By Type, 2020 (%)
mTOR Inhibitors
RAF/MEK Inhibitors
CDK Inhibitors

Global Non-Tyrosine Kinase Inhibitors Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Non-Tyrosine Kinase Inhibitors Market Segment Percentages, By Application, 2020 (%)
Liver Cancer
Respiratory Cancer
Brain Cancer
Others

Global Non-Tyrosine Kinase Inhibitors Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)
Global Non-Tyrosine Kinase Inhibitors Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Non-Tyrosine Kinase Inhibitors revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Non-Tyrosine Kinase Inhibitors revenues share in global market, 2020 (%)
Key companies Non-Tyrosine Kinase Inhibitors sales in global market, 2016-2021 (Estimated), (K Pcs)
Key companies Non-Tyrosine Kinase Inhibitors sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Eli Lilly
Novartis
Array BioPharma
Nerviano Medical Sciences
Pfizer
Merck KGaA
Astex Pharmaceuticals
Cyclacel Pharmaceuticals
Daiichi Sankyo
Onconova Therapeutics
AstraZeneca
GlaxoSmithKline (GSK)
Carna Biosciences
Celgene Corporation
Eternity Bioscience
Jasco Pharmaceuticals

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Non-Tyrosine Kinase Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Non-Tyrosine Kinase Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Non-Tyrosine Kinase Inhibitors Overall Market Size
2.1 Global Non-Tyrosine Kinase Inhibitors Market Size: 2021 VS 2027
2.2 Global Non-Tyrosine Kinase Inhibitors Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Non-Tyrosine Kinase Inhibitors Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Non-Tyrosine Kinase Inhibitors Players in Global Market
3.2 Top Global Non-Tyrosine Kinase Inhibitors Companies Ranked by Revenue
3.3 Global Non-Tyrosine Kinase Inhibitors Revenue by Companies
3.4 Global Non-Tyrosine Kinase Inhibitors Sales by Companies
3.5 Global Non-Tyrosine Kinase Inhibitors Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Non-Tyrosine Kinase Inhibitors Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Non-Tyrosine Kinase Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Non-Tyrosine Kinase Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Non-Tyrosine Kinase Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Non-Tyrosine Kinase Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Non-Tyrosine Kinase Inhibitors Market Size Markets, 2021 & 2027
4.1.2 mTOR Inhibitors
4.1.3 RAF/MEK Inhibitors
4.1.4 CDK Inhibitors
4.2 By Type - Global Non-Tyrosine Kinase Inhibitors Revenue & Forecasts
4.2.1 By Type - Global Non-Tyrosine Kinase Inhibitors Revenue, 2016-2021
4.2.2 By Type - Global Non-Tyrosine Kinase Inhibitors Revenue, 2022-2027
4.2.3 By Type - Global Non-Tyrosine Kinase Inhibitors Revenue Market Share, 2016-2027
4.3 By Type - Global Non-Tyrosine Kinase Inhibitors Sales & Forecasts
4.3.1 By Type - Global Non-Tyrosine Kinase Inhibitors Sales, 2016-2021
4.3.2 By Type - Global Non-Tyrosine Kinase Inhibitors Sales, 2022-2027
4.3.3 By Type - Global Non-Tyrosine Kinase Inhibitors Sales Market Share, 2016-2027
4.4 By Type - Global Non-Tyrosine Kinase Inhibitors Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Non-Tyrosine Kinase Inhibitors Market Size, 2021 & 2027
5.1.2 Liver Cancer
5.1.3 Respiratory Cancer
5.1.4 Brain Cancer
5.1.5 Others
5.2 By Application - Global Non-Tyrosine Kinase Inhibitors Revenue & Forecasts
5.2.1 By Application - Global Non-Tyrosine Kinase Inhibitors Revenue, 2016-2021
5.2.2 By Application - Global Non-Tyrosine Kinase Inhibitors Revenue, 2022-2027
5.2.3 By Application - Global Non-Tyrosine Kinase Inhibitors Revenue Market Share, 2016-2027
5.3 By Application - Global Non-Tyrosine Kinase Inhibitors Sales & Forecasts
5.3.1 By Application - Global Non-Tyrosine Kinase Inhibitors Sales, 2016-2021
5.3.2 By Application - Global Non-Tyrosine Kinase Inhibitors Sales, 2022-2027
5.3.3 By Application - Global Non-Tyrosine Kinase Inhibitors Sales Market Share, 2016-2027
5.4 By Application - Global Non-Tyrosine Kinase Inhibitors Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Non-Tyrosine Kinase Inhibitors Market Size, 2021 & 2027
6.2 By Region - Global Non-Tyrosine Kinase Inhibitors Revenue & Forecasts
6.2.1 By Region - Global Non-Tyrosine Kinase Inhibitors Revenue, 2016-2021
6.2.2 By Region - Global Non-Tyrosine Kinase Inhibitors Revenue, 2022-2027
6.2.3 By Region - Global Non-Tyrosine Kinase Inhibitors Revenue Market Share, 2016-2027
6.3 By Region - Global Non-Tyrosine Kinase Inhibitors Sales & Forecasts
6.3.1 By Region - Global Non-Tyrosine Kinase Inhibitors Sales, 2016-2021
6.3.2 By Region - Global Non-Tyrosine Kinase Inhibitors Sales, 2022-2027
6.3.3 By Region - Global Non-Tyrosine Kinase Inhibitors Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Non-Tyrosine Kinase Inhibitors Revenue, 2016-2027
6.4.2 By Country - North America Non-Tyrosine Kinase Inhibitors Sales, 2016-2027
6.4.3 US Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.4.4 Canada Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.4.5 Mexico Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Non-Tyrosine Kinase Inhibitors Revenue, 2016-2027
6.5.2 By Country - Europe Non-Tyrosine Kinase Inhibitors Sales, 2016-2027
6.5.3 Germany Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.5.4 France Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.5.5 U.K. Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.5.6 Italy Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.5.7 Russia Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.5.8 Nordic Countries Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.5.9 Benelux Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Non-Tyrosine Kinase Inhibitors Revenue, 2016-2027
6.6.2 By Region - Asia Non-Tyrosine Kinase Inhibitors Sales, 2016-2027
6.6.3 China Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.6.4 Japan Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.6.5 South Korea Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.6.6 Southeast Asia Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.6.7 India Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Non-Tyrosine Kinase Inhibitors Revenue, 2016-2027
6.7.2 By Country - South America Non-Tyrosine Kinase Inhibitors Sales, 2016-2027
6.7.3 Brazil Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.7.4 Argentina Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Non-Tyrosine Kinase Inhibitors Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Non-Tyrosine Kinase Inhibitors Sales, 2016-2027
6.8.3 Turkey Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.8.4 Israel Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.8.5 Saudi Arabia Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
6.8.6 UAE Non-Tyrosine Kinase Inhibitors Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Corporate Summary
7.1.2 Roche Business Overview
7.1.3 Roche Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.1.4 Roche Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.1.5 Roche Key News
7.2 Eli Lilly
7.2.1 Eli Lilly Corporate Summary
7.2.2 Eli Lilly Business Overview
7.2.3 Eli Lilly Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.2.4 Eli Lilly Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.2.5 Eli Lilly Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.3.4 Novartis Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.3.5 Novartis Key News
7.4 Array BioPharma
7.4.1 Array BioPharma Corporate Summary
7.4.2 Array BioPharma Business Overview
7.4.3 Array BioPharma Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.4.4 Array BioPharma Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.4.5 Array BioPharma Key News
7.5 Nerviano Medical Sciences
7.5.1 Nerviano Medical Sciences Corporate Summary
7.5.2 Nerviano Medical Sciences Business Overview
7.5.3 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.5.4 Nerviano Medical Sciences Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.5.5 Nerviano Medical Sciences Key News
7.6 Pfizer
7.6.1 Pfizer Corporate Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.6.4 Pfizer Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.6.5 Pfizer Key News
7.7 Merck KGaA
7.7.1 Merck KGaA Corporate Summary
7.7.2 Merck KGaA Business Overview
7.7.3 Merck KGaA Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.4.4 Merck KGaA Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.7.5 Merck KGaA Key News
7.8 Astex Pharmaceuticals
7.8.1 Astex Pharmaceuticals Corporate Summary
7.8.2 Astex Pharmaceuticals Business Overview
7.8.3 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.8.4 Astex Pharmaceuticals Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.8.5 Astex Pharmaceuticals Key News
7.9 Cyclacel Pharmaceuticals
7.9.1 Cyclacel Pharmaceuticals Corporate Summary
7.9.2 Cyclacel Pharmaceuticals Business Overview
7.9.3 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.9.4 Cyclacel Pharmaceuticals Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.9.5 Cyclacel Pharmaceuticals Key News
7.10 Daiichi Sankyo
7.10.1 Daiichi Sankyo Corporate Summary
7.10.2 Daiichi Sankyo Business Overview
7.10.3 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.10.4 Daiichi Sankyo Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.10.5 Daiichi Sankyo Key News
7.11 Onconova Therapeutics
7.11.1 Onconova Therapeutics Corporate Summary
7.11.2 Onconova Therapeutics Non-Tyrosine Kinase Inhibitors Business Overview
7.11.3 Onconova Therapeutics Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.11.4 Onconova Therapeutics Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.11.5 Onconova Therapeutics Key News
7.12 AstraZeneca
7.12.1 AstraZeneca Corporate Summary
7.12.2 AstraZeneca Non-Tyrosine Kinase Inhibitors Business Overview
7.12.3 AstraZeneca Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.12.4 AstraZeneca Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.12.5 AstraZeneca Key News
7.13 GlaxoSmithKline (GSK)
7.13.1 GlaxoSmithKline (GSK) Corporate Summary
7.13.2 GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors Business Overview
7.13.3 GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.13.4 GlaxoSmithKline (GSK) Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.13.5 GlaxoSmithKline (GSK) Key News
7.14 Carna Biosciences
7.14.1 Carna Biosciences Corporate Summary
7.14.2 Carna Biosciences Business Overview
7.14.3 Carna Biosciences Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.14.4 Carna Biosciences Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.14.5 Carna Biosciences Key News
7.15 Celgene Corporation
7.15.1 Celgene Corporation Corporate Summary
7.15.2 Celgene Corporation Business Overview
7.15.3 Celgene Corporation Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.15.4 Celgene Corporation Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.15.5 Celgene Corporation Key News
7.16 Eternity Bioscience
7.16.1 Eternity Bioscience Corporate Summary
7.16.2 Eternity Bioscience Business Overview
7.16.3 Eternity Bioscience Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.16.4 Eternity Bioscience Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.16.5 Eternity Bioscience Key News
7.17 Jasco Pharmaceuticals
7.17.1 Jasco Pharmaceuticals Corporate Summary
7.17.2 Jasco Pharmaceuticals Business Overview
7.17.3 Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors Major Product Offerings
7.17.4 Jasco Pharmaceuticals Non-Tyrosine Kinase Inhibitors Sales and Revenue in Global (2016-2021)
7.17.5 Jasco Pharmaceuticals Key News
8 Global Non-Tyrosine Kinase Inhibitors Production Capacity, Analysis
8.1 Global Non-Tyrosine Kinase Inhibitors Production Capacity, 2016-2027
8.2 Non-Tyrosine Kinase Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Non-Tyrosine Kinase Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Non-Tyrosine Kinase Inhibitors Supply Chain Analysis
10.1 Non-Tyrosine Kinase Inhibitors Industry Value Chain
10.2 Non-Tyrosine Kinase Inhibitors Upstream Market
10.3 Non-Tyrosine Kinase Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Non-Tyrosine Kinase Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Non-Tyrosine Kinase Inhibitors in Global Market
Table 2. Top Non-Tyrosine Kinase Inhibitors Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Non-Tyrosine Kinase Inhibitors Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Non-Tyrosine Kinase Inhibitors Revenue Share by Companies, 2016-2021
Table 5. Global Non-Tyrosine Kinase Inhibitors Sales by Companies, (K Pcs), 2016-2021
Table 6. Global Non-Tyrosine Kinase Inhibitors Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Non-Tyrosine Kinase Inhibitors Price (2016-2021) & (USD/Pcs)
Table 8. Global Manufacturers Non-Tyrosine Kinase Inhibitors Product Type
Table 9. List of Global Tier 1 Non-Tyrosine Kinase Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Non-Tyrosine Kinase Inhibitors Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Roche
Eli Lilly
Novartis
Array BioPharma
Nerviano Medical Sciences
Pfizer
Merck KGaA
Astex Pharmaceuticals
Cyclacel Pharmaceuticals
Daiichi Sankyo
Onconova Therapeutics
AstraZeneca
GlaxoSmithKline (GSK)
Carna Biosciences
Celgene Corporation
Eternity Bioscience
Jasco Pharmaceuticals

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE